Astria Therapeutics, Inc. (NASDAQ:ATXS) Q3 2023 Earnings Call Transcript November 13, 2023 Astria Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.63 EPS, expectations were $-0.51. Operator: Good morning and welcome to the Astria Therapeutics Quarter Three 2023 Corporate Update. At this time, all attendees are in a listen-only mode. [Operator Instructions] As a […]

Related Keywords

, Andrea Matthews , David Shaw Quant , Noah Clauser , Christopher Morabito , Andrew Komjathy , Amgen , Chief Business Officer , Chief Financial Officer , Pivotal Phase , Hedge Funds , Wall Street Analysts Are Crazy About , Billionaire David Shaw , Quant Models Love These , Atopic Dermatitis , Chief Commercial Officer , Jill Milne , Chief Executive Officer ,